Panagora Asset Management Inc Red Hill Biopharma Ltd. Transaction History

Panagora Asset Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$5.98 - $7.51 $5,537 - $6,954	-926 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$6.98 - $11.29 $7,294 - $11,798	-1,045 Reduced 53.02%	926 $7,000
Q4 2020 Feb 10, 2021	SELL	$7.81 - $10.39 $359 - $477	-46 Reduced 2.28%	1,971 $16,000
Q3 2020 Nov 13, 2020	BUY	$6.34 - $10.83 $12,787 - $21,844	2,017 New	2,017 $21,000

40.4K

Ticker RDHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 63,823,500
Market Cap $465M
Description
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.